These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34546037)

  • 41. Application of different types of CRISPR/Cas-based systems in bacteria.
    Liu Z; Dong H; Cui Y; Cong L; Zhang D
    Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine.
    Tao P; Mahalingam M; Marasa BS; Zhang Z; Chopra AK; Rao VB
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5846-51. PubMed ID: 23530211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
    Wada N; Osakabe K; Osakabe Y
    Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of phage display-modified bacteriophage T4 by affinity chromatography.
    Oślizło A; Miernikiewicz P; Piotrowicz A; Owczarek B; Kopciuch A; Figura G; Dąbrowska K
    BMC Biotechnol; 2011 May; 11():59. PubMed ID: 21627821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines.
    Li M; Chen C; Wang X; Guo P; Feng H; Zhang X; Zhang W; Gu C; Zhu J; Wen G; Feng Y; Xiao L; Peng G; Rao VB; Tao P
    Antiviral Res; 2023 Sep; 217():105688. PubMed ID: 37516153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scarless Cas9 Assisted Recombineering (no-SCAR) in Escherichia coli, an Easy-to-Use System for Genome Editing.
    Reisch CR; Prather KLJ
    Curr Protoc Mol Biol; 2017 Jan; 117():31.8.1-31.8.20. PubMed ID: 28060411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of a series of episomal plasmids and their application in the development of an efficient CRISPR/Cas9 system in Pichia pastoris.
    Gu Y; Gao J; Cao M; Dong C; Lian J; Huang L; Cai J; Xu Z
    World J Microbiol Biotechnol; 2019 May; 35(6):79. PubMed ID: 31134410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
    Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
    Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uncovering the determinants of model Escherichia coli strain C600 susceptibility and resistance to lytic T4-like and T7-like phage.
    Wang M; Zhu H; Wei J; Jiang L; Jiang L; Liu Z; Li R; Wang Z
    Virus Res; 2023 Feb; 325():199048. PubMed ID: 36681192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.
    Box AM; McGuffie MJ; O'Hara BJ; Seed KD
    J Bacteriol; 2016 Feb; 198(3):578-90. PubMed ID: 26598368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing.
    Liu R; Liang L; Freed EF; Gill RT
    Trends Biotechnol; 2021 Mar; 39(3):262-273. PubMed ID: 32828556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular architecture of the prolate head of bacteriophage T4.
    Fokine A; Chipman PR; Leiman PG; Mesyanzhinov VV; Rao VB; Rossmann MG
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6003-8. PubMed ID: 15071181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophage genome engineering with CRISPR-Cas13a.
    Guan J; Oromí-Bosch A; Mendoza SD; Karambelkar S; Berry JD; Bondy-Denomy J
    Nat Microbiol; 2022 Dec; 7(12):1956-1966. PubMed ID: 36316452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes.
    Li Q; Shivachandra SB; Leppla SH; Rao VB
    J Mol Biol; 2006 Oct; 363(2):577-88. PubMed ID: 16982068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR/Cas genome editing in plants: Dawn of Agrobacterium transformation for recalcitrant and transgene-free plants for future crop breeding.
    Antony Ceasar S; Ignacimuthu S
    Plant Physiol Biochem; 2023 Mar; 196():724-730. PubMed ID: 36812799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.